About this medicine
- Approved name
- Priligy
- International non-proprietary name (INN) or common name
- dapoxetine
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-29/1294
- Type
- Article 29(4) referrals
This type of referral is triggered when there is a disagreement between Member States regarding a marketing authorisation application being evaluated in a mutual-recognition or decentralised procedure, on the grounds of a potential serious risk to public health.
Key dates and outcomes
- CHMP opinion date
- 20/10/2011
- EC decision date
- 20/01/2012